임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 중· Moderately to Severely Active Crohns DiseaseA Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
리드: 로슈
- 3상모집 중· Peripheral Artery Disease (PAD)Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
리드: 리제네론
- 3상모집 중· Hidradenitis SuppurativaAn Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
리드: 노바티스
- 3상모집 중· Type 2 Diabetes MellitusA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
리드: 아스트라제네카
- 3상모집 중· Venous Thromboembolism (VTE)Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
리드: 리제네론
- 3상모집 중· Diphtheria-Tetanus-acellular Pertussis VaccinesA Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years
리드: GSK
- 3상모집 중· Diphtheria-Tetanus-acellular Pertussis VaccinesA Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women
리드: GSK
- 3상모집 중· Non-small Cell Lung CancerA Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
리드: 머크(MSD)
- 3상모집 중· Primary Myelofibrosis (PMF)A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
리드: 노바티스
- 3상모집 중· ER-Positive HER2-Negative Breast CancerA Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
리드: 아스트라제네카
- 3상모집 중· Pneumococcal DiseaseStudy to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
리드: 화이자
- 3상모집 중· Paroxysmal Nocturnal HemoglobinuriaA Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
리드: 리제네론
- 3상모집 중· Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
리드: 노바티스
- 3상모집 중· Multiple MyelomaA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중· Pneumococcal DiseaseA Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
리드: 화이자
- 3상모집 중· Neovascular Age-related Macular DegenerationA Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
리드: 암젠
- 3상모집 중· Colitis, UlcerativeA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Alzheimer DiseaseA Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
리드: 일라이 릴리
- 3상모집 중· Relapsed or Refractory Large B-cell LymphomaStudy Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
협력: 길리어드
- 3상모집 중· Crohn DiseaseA Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중· High Risk Smoldering Multiple Myeloma (HR-SMM)A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
리드: 리제네론
- 3상모집 중· Cardiovascular Disease and Lipoprotein(a)An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
리드: 노바티스
- 3상모집 중· Respiratory Syncytial Virus (RSV)A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
리드: 화이자
- 3상모집 중· Chronic Obstructive Pulmonary DiseaseLong-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
리드: 아스트라제네카
- 3상모집 중· Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHVSurovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
리드: 아스트라제네카
- 3상모집 중· Metastatic Castration-resistant Prostate CancerAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
리드: 아스트라제네카
- 3상모집 중· Non-small Cell Lung CancerA Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
리드: 머크(MSD) · 협력: 모더나
- 3상모집 중· Pneumococcal DiseaseA Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
리드: 화이자
- 3상모집 중· Depressive Disorder, MajorA Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Alzheimer DiseaseDonanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
리드: 일라이 릴리
- 3상모집 중· Chronic Rhinosinusitis With Nasal PolypsA Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
리드: 아스트라제네카
- 3상모집 중· Bladder CancerA Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
리드: 머크(MSD)
- 3상모집 중· Metastatic Castration-resistant Prostate CancerA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
리드: 바이오엔테크
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.